Literature DB >> 1933421

N6-cyclopentyladenosine impairs passive avoidance retention by selective action at A1 receptors.

H J Normile1, R A Barraco.   

Abstract

The effects of N6-cyclopentyladenosine (CPA), a highly selective agonist for adenosine A1 receptors, on retention of one-trial inhibitory avoidance behavior were examined in mice. Water-deprived animals were trained to avoid drinking by pairing foot-shock with licks from a water spout. Retention was measured as the suppression of drinking (latency to drink) 48 h following training. Administration of CPA (0.15-2.25 mumol/kg) 30 min prior to training produced a dose-dependent impairment in memory of the original avoidance task. The CPA-elicited deficits in retention performance were blocked by pretreatment with 8-cyclopentyl-1,3-dipropylxanthine (DPCPX), a selective A1 receptor antagonist; DPCPX (15 mumol/kg) administration alone had no effect on retention performance. These findings suggest that selective activation of a presumably central population of A1 receptors may impair retention performance and influence information processing.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1933421     DOI: 10.1016/0361-9230(91)90288-u

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  11 in total

1.  Neuromodulatory effect of propentofylline on rat brain under acute and long-term hypoperfusion.

Authors:  K Plaschke; M Grant; M A Weigand; J Züchner; E Martin; H J Bardenheuer
Journal:  Br J Pharmacol       Date:  2001-05       Impact factor: 8.739

Review 2.  Adenosine hypothesis of schizophrenia--opportunities for pharmacotherapy.

Authors:  Detlev Boison; Philipp Singer; Hai-Ying Shen; Joram Feldon; Benjamin K Yee
Journal:  Neuropharmacology       Date:  2011-02-17       Impact factor: 5.250

3.  Chronic treatment with DCPCX, an adenosine A(1) antagonist, worsens long-term memory.

Authors:  Craig Vollert; Gloria S Forkuo; Richard A Bond; Jason L Eriksen
Journal:  Neurosci Lett       Date:  2013-06-06       Impact factor: 3.046

4.  Mice lacking the adenosine A1 receptor have normal spatial learning and plasticity in the CA1 region of the hippocampus, but they habituate more slowly.

Authors:  Lydia Giménez-Llort; Susan A Masino; Lihong Diao; Alberto Fernández-Teruel; Adolf Tobeña; Linda Halldner; Bertil B Fredholm
Journal:  Synapse       Date:  2005-07       Impact factor: 2.562

5.  Effects of purine analogues on spontaneous alternation in mice.

Authors:  N Hooper; C Fraser; T W Stone
Journal:  Psychopharmacology (Berl)       Date:  1996-02       Impact factor: 4.530

6.  Adenosine A1 receptor antagonist rolofylline alleviates axonopathy caused by human Tau ΔK280.

Authors:  Frank J A Dennissen; Marta Anglada-Huguet; Astrid Sydow; Eckhard Mandelkow; Eva-Maria Mandelkow
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-26       Impact factor: 11.205

7.  Effects of chronic administration of adenosine A1 receptor agonist and antagonist on spatial learning and memory.

Authors:  D K Von Lubitz; I A Paul; R T Bartus; K A Jacobson
Journal:  Eur J Pharmacol       Date:  1993-11-16       Impact factor: 4.432

Review 8.  Adenosine receptor ligands: differences with acute versus chronic treatment.

Authors:  K A Jacobson; D K von Lubitz; J W Daly; B B Fredholm
Journal:  Trends Pharmacol Sci       Date:  1996-03       Impact factor: 14.819

9.  Chronic adenosine A1 receptor agonist and antagonist: effect on receptor density and N-methyl-D-aspartate induced seizures in mice.

Authors:  D K Von Lubitz; I A Paul; X D Ji; M Carter; K A Jacobson
Journal:  Eur J Pharmacol       Date:  1994-02-21       Impact factor: 4.432

Review 10.  Exploration of chalcones and related heterocycle compounds as ligands of adenosine receptors: therapeutics development.

Authors:  Chrisna Matthee; Gisella Terre'Blanche; Lesetja J Legoabe; Helena D Janse van Rensburg
Journal:  Mol Divers       Date:  2021-06-27       Impact factor: 3.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.